CMPX

COMPASS THERAPEUTICS INC

CMPX·20454B104·US·Common Stock·Healthcare - Biotechnology-Activist

CMPX (COMPASS THERAPEUTICS INC) is held by 112 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($50.3M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($44.9M), STATE STREET CORP ($35.4M). Net institutional sentiment: Bullish.

112
Holders
(11 Elite)
$379.2M
Total Value
73% (111)
Consensus
81 buying - 30 selling
13F: Insider & Congress:
CMPXSmart Money Verdict
View all
Held by 112 funds
11 elite
Who's Trading
ActivistBLBVF PARTNERS L P/IL4.3%May 15, 2026
InsiderLNLerner NeilBuy $28KApr 29, 2026
InsiderAJAnderman JonathanBuy $47KApr 29, 2026
ActivistBABlackstone Annex Master Fund L.P.1.4%Feb 13, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.2%Jan 21, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC10.0%Nov 14, 2025
ActivistVOVivo Opportunity Fund Holdings, L.P.5.1%Nov 14, 2025
ActivistSUSuvretta Capital Management, LLC8.2%Aug 21, 2025
InsiderSJSchuetz Thomas J.Buy $21KMay 27, 2025
InsiderGLGORDON CARL LSell $5.7MApr 9, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.5M(+1.3%)$50.3M0.0%-10.53%
30
Increased
8.5M(+91.3%)$44.9M0.1%-42.09%
46
Increased
6.7M(+36.9%)$35.4M0.0%-42.33%
38
New
6M$31.9M0.0%-57.87%
40
Increased
4.2M(+67.5%)$22.1M0.2%-48.32%
50
Increased
3.6M(+1.8%)$18.9M0.0%-29.43%
29
Increased
2.6M(+477.3%)$13.5M0.0%-57.67%
45
Increased
2.4M(+1324.6%)$12.7M0.0%-55.96%
45
Increased
2M(+31.5%)$10.6M0.0%-47.84%
35
Decreased
1.9M(-69.7%)$9.8M0.0%-23.56%
0
Decreased
1.8M(-30.2%)$9.5M0.0%+57.25%
0
Increased
1.6M(+466.4%)$8.6M0.1%-57.66%
44
Increased
1.6M(+94.0%)$8.4M0.0%-57.27%
44
New
1.3M$7.1M0.0%-57.87%
38
Decreased
1.1M(-29.8%)$5.9M0.0%-39.01%
0
New
1.1M$5.7M0.0%-57.87%
37
Increased
1.1M(+137.8%)$5.7M0.0%-51.57%
44
Increased
1M(+7.8%)$5.5M0.0%-32.35%
29
New
998,140$5.3M0.0%-57.87%
37
Increased
865,613(+224.9%)$4.6M0.0%-55.84%
43

Showing 1-20 of 117

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used